IL17A and irritable bowel syndrome: As shown in Fig. 8, compared with the control group, the intestinal IL-17 level in PI-IBS patients significantly increased (p < 0.05), while the IFN-γ level remained unchanged (p > 0.05), suggesting that the local IL-17 could participate in the intestinal pathological disorder during PI-IBS.